Back to results
US 2023/0414726 A1Published application
Respirable aqueous pharmaceutical composition comprising a polypeptide for corona virus treatment and neutralization
AssigneeMasker Med Tech AB
InventorsGyörgy MARKO-VARGA, Yutaka SUGIHARA, Jeovanis GIL VALDÉS, Roger APPELQVIST, Johan MALM
Life of this patent
Estimating the term…
Abstract
A respirable aqueous pharmaceutical composition comprising a neutralizing affinity binder for a virus binding to angiotensin-converting enzyme 2 (ACE2), a buffer, and a solubilizer.
Claims30
A respirable aqueous pharmaceutical composition, comprising a neutralizing affinity binder for a virus binding to angiotensin-converting enzyme 2 (ACE2), a buffer, and a solubilizer.
Dependencies are inferred from the claim text.